CME Group amends bylaws for Universal Proxy Rules compliance, removes Class B Nominating Committee references

CME GROUP INC.

Board approved and adopted Amended Bylaws effective Dec 7, 2022, addressing Universal Proxy Rule 14a-19.
Requires evidence of shareholder compliance with Universal Proxy solicitation requirements.
Company provided a remedy if a shareholder fails to satisfy Universal Proxy Rules.
Removed references to Class B Nominating Committees, which concluded as of 2020 Annual Meeting.
Also includes non-substantive and clarifying changes to Bylaws.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

CME GROUP INC.: Amended and Restated Bylaws to address Universal Proxy Rules, including shareholder solicitation requirements and removal of Class B Nominating Committee references (effective 2022-12-07).

Change: bylaw amendment
Effective: 2022-12-07

Exact text from the filing

On December 7, 2022, the Board of Directors (the “Board”) of CME Group Inc. (the “Company”) approved and adopted Amended and Restated Bylaws of the Corporation (the “Amended Bylaws”), effective December 7, 2022, in order to, among other things, address matters relating to Rule 14a-19 (the “Universal Proxy Rules”) under the Securities Exchange Act of 1934, as amended.

View on SEC.gov

Browse all governance changes →

CME GROUP INC. filing history →

Source: SEC EDGAR

accession 0001193125-22-301477

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.